Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

The S&P 500 ticked 0.1% higher on Thursday, April 17, wrapping up a shortened week that focused on earnings and the Federal Reserve chair's comments on likely tariff impacts.

Christopher appeared slimmed-down while hanging with his siblings, Katherine Schwarzenegger, Christina Schwarzenegger and Patrick Schwarzenegger.

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

If you're eating less, moving more, and still not seeing the number on the scale go down, you may be wondering: "Why am I not ...

Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of 16 pounds.

However, it's entirely possible to lose fat while building muscle, leaving you stronger than when you began working out.

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

“There is some evidence that there is altered brain activity related to reward-related behaviors, including appetite and ...

Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...